Literature DB >> 12620743

HIV vaccine fails in phase 3 trial.

Michael McCarthy.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12620743     DOI： 10.1016/S0140-6736(03)12669-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.

Authors:  Ma Luo; Christina A Daniuk; Tamsir O Diallo; Rupert E Capina; Joshua Kimani; Charles Wachihi; Makubo Kimani; Thomas Bielawny; Trevor Peterson; Mark G R Mendoza; Sandra Kiazyk; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

3.  Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV.

Authors:  Anne S De Groot; Daniel S Rivera; Julie A McMurry; Soren Buus; William Martin
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

4.  Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine.

Authors:  Lauren Levitz; Ousmane A Koita; Kotou Sangare; Matthew T Ardito; Christine M Boyle; John Rozehnal; Karamoko Tounkara; Sounkalo M Dao; Youssouf Koné; Zoumana Koty; Soren Buus; Leonard Moise; William D Martin; Anne S De Groot
Journal:  Vaccine       Date:  2012-10-24       Impact factor: 3.641

Review 5.  Mucosal immunology of HIV infection.

Authors:  Huanbin Xu; Xiaolei Wang; Ronald S Veazey
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

6.  A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement.

Authors:  Yuanyong Xu; Chuanfu Zhang; Leili Jia; Cuirong Wen; Huihui Liu; Yong Wang; Yansong Sun; Liuyu Huang; Yusen Zhou; Hongbin Song
Journal:  Virol J       Date:  2009-08-12       Impact factor: 4.099

7.  International network for comparison of HIV neutralization assays: the NeutNet report II.

Authors:  Leo Heyndrickx; Alan Heath; Enas Sheik-Khalil; Jose Alcami; Vera Bongertz; Marianne Jansson; Mauro Malnati; David Montefiori; Christiane Moog; Lynn Morris; Saladin Osmanov; Victoria Polonis; Meghna Ramaswamy; Quentin Sattentau; Monica Tolazzi; Hanneke Schuitemaker; Betty Willems; Terri Wrin; Eva Maria Fenyö; Gabriella Scarlatti
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

8.  PLoS takes a step backward.

Authors:  John J Pippin
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.069

9.  International network for comparison of HIV neutralization assays: the NeutNet report.

Authors:  Eva Maria Fenyö; Alan Heath; Stefania Dispinseri; Harvey Holmes; Paolo Lusso; Susan Zolla-Pazner; Helen Donners; Leo Heyndrickx; Jose Alcami; Vera Bongertz; Christian Jassoy; Mauro Malnati; David Montefiori; Christiane Moog; Lynn Morris; Saladin Osmanov; Victoria Polonis; Quentin Sattentau; Hanneke Schuitemaker; Ruengpung Sutthent; Terri Wrin; Gabriella Scarlatti
Journal:  PLoS One       Date:  2009-02-20       Impact factor: 3.240

10.  From GRID to gridlock: the relationship between scientific biomedical breakthroughs and HIV/AIDS policy in the US Congress.

Authors:  Matthew B Platt; Manu O Platt
Journal:  J Int AIDS Soc       Date:  2013-11-27       Impact factor: 5.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.